Ticagrelor, a P2Y12 antagonist, attenuates vascular dysfunction and inhibits atherogenesis in apolipoprotein-E-deficient mice
- 1 August 2018
- journal article
- research article
- Published by Elsevier in Atherosclerosis
- Vol. 275, 124-132
Abstract
No abstract availableKeywords
Funding Information
- Boehringer Ingelheim
- Tanabe-Mitsubishi
- Kowa
- Actelion
- Japan Society for the Promotion of Science KAKENHI (16K09517, 16H05299, 26248050)
- Takeda Science Foundation
- Fugaku Trust for Medical Research
- Vehicle Racing Commemorative Foundation
This publication has 43 references indexed in Scilit:
- The platelet P2Y12 receptor for adenosine diphosphate: congenital and drug-induced defectsBlood, 2011
- Regulation of Functionally Active P2Y12 ADP Receptors by Thrombin in Human Smooth Muscle Cells and the Presence of P2Y12 in Carotid Artery LesionsArteriosclerosis, Thrombosis, and Vascular Biology, 2010
- Clopidogrel attenuates atheroma formation and induces a stable plaque phenotype in apolipoprotein E knockout miceMicrovascular Research, 2009
- ACC/AHA 2007 Guidelines for the Management of Patients With Unstable Angina/Non–ST-Elevation Myocardial InfarctionJACC, 2007
- Clopidogrel Improves Systemic Endothelial Nitric Oxide Bioavailability in Patients With Coronary Artery DiseaseArteriosclerosis, Thrombosis, and Vascular Biology, 2006
- Adenosine receptors and the control of endothelial cell function in inflammatory diseaseImmunology Letters, 2005
- Inflammation, Atherosclerosis, and Coronary Artery DiseaseNew England Journal of Medicine, 2005
- NADPH oxidase mediates vascular endothelial cadherin phosphorylation and endothelial dysfunctionBlood, 2004
- Inflammation in atherosclerosisNature, 2002
- Characterization and Channel Coupling of the P2Y12Nucleotide Receptor of Brain Capillary Endothelial CellsJournal of Biological Chemistry, 2002